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Background: Data on the impact of asthma in many countries in the Asia-Pacific region is
limited. This study investigated whether partly- and uncontrolled asthma were associated with
increased medication use/healthcare utilization and productivity loss among a population of
asthma patients from nine Asia-Pacific countries.
Methods: We used cross-sectional data from 3630 asthma patients12 years from the 2011 Asia-
Pacific Asthma Insights and Management (AP-AIM) survey. Using Global Initiative for Asthma
(GINA) guidelines, patients were categorized as having well-controlled, partly- controlled, or un-
controlled asthma. Chi-square tests were used to assess the relation of degree of asthma control
with utilization of asthma medications, health services, productivity, and mood.
Results: Overall, 7.6% of the patients surveyed had asthma that was well-controlled, with the
highest proportions in Singapore (14%) and the lowest in India (0%) and China (2%). Patients
whose asthma was not well-controlled reported greater use of asthma medications, more emer-
gency healthcare visits or hospitalizations for their asthma, and more interference of their mood
due to asthma. They also reported significant decreases in productivity due to asthma.
Conclusions: Patients who did not have well-controlled asthma had greater utilization rates of
asthma medications and healthcare services and were more likely to report missing multiple days
of work/school compared to patients whose asthma was well-controlled. These associations sug-
gest that emphasis on improving asthma control could have dramatic effects on patient well-
being and utilization of healthcare resources.
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A World Health Survey conducted in 2002e2003 estimated
that 3e6% of the 4.2 billion residents of Asian-Pacific
countries have asthma and, although data are sparse, the
prevalence of asthma in most of these countries is believed
to be increasing [1e3]. Asthma causes significant morbidity
in Asia-Pacific countries. In the 2003 Asthma Insights and
Reality in Asia-Pacific (AIRIAP) Study, 44% of the re-
spondents reported at least one unscheduled emergency
healthcare visit for treatment of asthma in the previous
year [4]. Additionally, some of the highest mortality rates
from asthma are in Asia-Pacific countries [1]. Although
affordable medications that have been shown to be highly
effective at managing asthma have been available since the
1990s [5], the majority of patients worldwide, including in
Asia-Pacific countries [6], do not have well-controlled
asthma. The economic burden of asthma in terms of both
direct and indirect costs has been shown to be substantial-
a recent U.S. study estimated that the total annual cost of
asthma was $56 billion [7] and substantial costs have also
been attributed to asthma in Asian-Pacific settings [8,9].
Because the economic and societal impacts of asthma are
almost certainly correlated with disease severity, we con-
ducted these analyses to shed light on the relationship
between degree of asthma control and utilization of health
services and reduced productivity.
Over the past decade, physiological measurements of
asthma control, such as forced expiratory volume in one
second (FEV1), have been replaced with symptom and
quality-of-life questionnaires to define asthma control.
The Global Initiative for Asthma (GINA) and the United
States National Asthma Education Prevention Program
(NAEPP) revised their guidelines to focus on regulating
asthma symptoms, rather than lung function, in order to
maintain normal daily activity levels [10,11]. We recently
conducted studies on asthma patients in the U.S. and in
Latin America that demonstrated that asthma that is not
well-controlled according to GINA guidelines is associated
with increased rates of adverse outcomes compared to
asthma that is well-controlled [12]. The purpose of the
current study was to investigate whether partly- and un-
controlled asthma are associated with outcomes such as
increased medication use, visits to healthcare providers,
hospital admissions, and decreases in productivity among
a population of asthma patients from nine Asia-Pacific
countries. Determining whether uncontrolled asthma is
associated with these costly health outcomes is an
important step toward lessening the burden of this disease
in these countries.
Methods
Asia-Pacific Asthma Insights and Management
(AP-AIM) survey
Details about theAsia-PacificAsthma Insights andManagement
(AP-AIM) survey have been described previously [6]. In brief,
thecross-sectionalAP-AIM surveywasdesigned tocomplement
theUnited States AIM (US-AIM) survey andwas conducted from
FebruaryeJuly 2011. Subjects included in our analyses were3630 asthmapatients12 years old identified froma sampleof
57,131 households in Australia, China, Hong Kong, India,
Malaysia, Singapore,SouthKorea,Taiwan,andThailand.These
countries were non-randomly selected based on population
size, accessibility, andcost of survey implementation. Patients
were selected by random digit dialing and interviews were
conducted by telephone in Australia, China, and Hong Kong.
Patients were selected by random face-to-face interviews at
pre-specified locations and were conducted in person in the
remaining countries. Both telephone and in-person interviews
averaged 35 min in length. For subjects between 12 and 17
years, the survey was completed by a parent or guardian. In
order to be included in this study, patients had to have
answered that they had been diagnosed with asthma AND that
they were currently taking medications for their asthma or
they had had an asthma attack or asthma symptoms in the
previous 12 months. The 53 questions in this survey were
drafted in English as part of the US-AIM survey and were then
translated into local languages. The questions were designed
to assess asthma burden (short- and long-term symptoms,
functional impact, and healthcare utilization such as provider
visits and use of asthma medications) and patient beliefs on
appropriate use of medications for asthma control. Patients
werealsoasked toassess their (or their children’s) productivity
on a scale of 0e100% on both typical days and on days when
their asthma was at its worst. Additionally, demographic vari-
ables, such as gender, age, smoking status, education level,
and diagnosis of nasal allergies, were also queried.
Classification of asthma control
Patients were characterized based on GINA guidelines [10]
into three categories of level of asthma control: well-
controlled, partly- controlled, and uncontrolled (Table 1).
The manifestations of asthma that were used for the catego-
rizations included daytime symptoms, restriction of daily ac-
tivities, nighttime symptoms, and need for reliever/rescue
treatment. We used questions from the surveys that corre-
lated with the GINA-defined asthma manifestations, with the
exception of a lung function measurement <80% predicted,
because lung function measurement data were not obtained.
Statistical analysis
Frequencies, chi-square, and Fisher’s exact tests were
calculated for demographic variables such as age, gender,
country of residence, family history of asthma, and level of
education. Next, using chi-square tests, differences by
GINA-defined level of asthma control in rates of utilization
of asthma-related medications, use of healthcare services,
and effects of asthma on patient mood and productivity
were examined. For an analysis of the relationship of level
of asthma control with productivity and the number of days
of missed school/work, KruskaleWallis tests were used to
detect the significance of the means of the different levels
of asthma control.
All analyses were conducted using SAS for Windows,
Version 9.3 (SAS Institute, Inc, Cary, NC).
Because the data used for this paper did not include
individually identifiable data, nor could the data be linked to
specific individuals, this study was deemed not to meet the
Table 1 Survey questions used to categorize level of asthma control as defined by Global Initiative for Asthma guidelines.
GINA characteristic AP-AIM survey question(s) Response:
controlled
Response: partly-
controlled
Response: not
controlled
Daytime symptoms “In the past 4 weeks have you (your child)
had cough, wheezing, shortness of breath,
or chest tightness during the day?”
Twice or less per
week
Most days or
every day
Three or more
features of
partly- controlled
asthma
Limitation of activities “Do you feel your (your child’s) asthma
limits you (your child) a lot, some, only
a little or not at all in sports and
recreation/normal physical exertion/OR
daily activities?”
Not at all Any
Nocturnal symptoms/
awakening
“In the past four weeks, have you
(your child) been awakened by a cough,
or wheezing, or shortness of breath,
or chest tightness during the night?”
No Yes
Need for reliever/
rescue treatment
“How often do you (does your child)
use an inhaler for quick relief or rescue
from asthma symptoms?”
1e2 times a week
or less
Daily or 3e6 times
a week
Abbreviations: AP-AIM, Asia-Pacific Asthma Insights and Management, GINA, Global Initiative for Asthma.
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and hence was exempt from Human Subjects review by the
University of Washington Institutional Review Board.
Results
Frequencies and results of chi-square tests of demographic
variables, stratified by GINA-defined level of asthma control,
are presented in Table 2. Few patients in our study (7.6%)
had asthma that was classified as well-controlled. Younger
patients were slightly more likely than older patients to have
had asthma that was classified as well-controlled (13% of
patients aged 12e17 had well-controlled asthma, compared
to 5% of patients aged 51þ). Australia and Singapore had the
highest proportion of patients whose asthma was classified
as well-controlled (13% and 14%, respectively) and India and
China had the lowest (0% and 2.0%, respectively). Patients
who had a previous diagnosis of rhinitis were more likely to
have had well-controlled asthma compared to patients who
had not been diagnosed with rhinitis (9% compared to 6%). A
higher proportion of asthma patients who lived in the same
household as a smoker had uncontrolled asthma (32% versus
28%). Although the relationship was not statistically signifi-
cant, higher levels of education were associated with having
asthma that was classified as well-controlled compared to
patients with less education. We did not observe meaningful
differences of level of asthma control by gender, whether a
family member outside the household had been diagnosed
with asthma, or whether any pets were in the household.
Associations between past twelve months-use of asthma
medications and healthcare services, again stratified by
level of asthma control, are presented in Table 3.
Compared to patients with well-controlled asthma, greater
proportions of patients with partly- and uncontrolled
asthma used oral steroid, quick relief or rescue medica-
tions, long-term maintenance medications, and had un-
scheduled healthcare visits, hospitalizations, and visits to
their healthcare providers for asthma. Additionally,patients with partly- and uncontrolled asthma were more
likely to have missed work or school compared to patients
with well-controlled asthma.
Effects of asthma on several indicators of mood are
presented in Table 4. Patients with partly- and uncontrolled
asthma were significantly more likely to report that asthma
often or sometimes made them tired, fearful, depressed,
embarrassed, and frustrated compared to patients with
well-controlled asthma. Additionally, patients with partly-
and uncontrolled asthma were significantly more likely to
report feeling lack of control of their lives, inadequate in
relation to their peers, and that asthma affected how they
felt about themselves compared to patients with well-
controlled asthma.
Finally, Table 5 indicates the impact of asthma on the
productivity of respondents on typical days and when asthma
was worst. Compared to patients whose asthma was classi-
fied as well-controlled, patients with partly- and uncon-
trolled asthma had significantly lower productivity on typical
days and on days that asthma was worst. This table also
demonstrates that patients with partly- and uncontrolled
asthma missed significantly more days of work or school in
the previous year (an average of 3.7 and 7.9 days) compared
to patients with well-controlled asthma (average of <1 day).Discussion
The results of this research show that patients residing in
nine Asia-Pacific countries who had asthma that was clas-
sified according to the 2010 GINA Guidelines as partly- and
uncontrolled had greater utilization of asthma medications
and healthcare services compared to patients whose
asthma was classified as well-controlled. Additionally, pa-
tients with partly- and uncontrolled asthma were signifi-
cantly more likely to report that asthma affected their
mood, as well as absences from work and school and de-
creases in their productivity as a result of their asthma.
Table 2 Frequencies of descriptive variables of Asia-Pacific asthma insights and management survey respondents.
Total
(n Z 3630)
Well-controlled
n Z 276 (7.6%)
Partly controlled
n Z 2271 (63%)
Uncontrolled
n Z 1083 (30%)
Chi-square
p-Value
Age
12e17 442 57 (13%) 279 (63%) 106 (24%) <0.0001
18e35 987 86 (9%) 654 (66%) 247 (25%)
36e50 1027 71 (7%) 631 (61%) 325 (32%)
51þ 1174 62 (5%) 707 (60%) 405 (35%)
Female 2174 156 (7%) 1380 (63%) 638 (29%)
Male 1455 120 (8%) 891 (61%) 444 (31%) 0.30
Country of residence
Australia 403 52 (13%) 256 (64%) 95 (24%)
China 402 8 (2%) 225 (56%) 169 (42%)
Hong Kong 412 46 (11%) 300 (73%) 66 (16%)
India 400 0 241 (60%) 159 (40%)
Malaysia 413 26 (6%) 262 (63%) 125 (30%)
Singapore 400 54 (14%) 244 (61%) 102 (26%)
South Korea 400 33 (8%) 220 (55%) 147 (37%)
Taiwan 400 24 (6%) 290 (73%) 86 (22%)
Thailand 400 33 (8%) 233 (58%) 134 (34%) <0.0001
Asthma patient had diagnosis of rhinitis 1838 163 (9%) 1137 (65%) 447 (26%)
Asthma patient did not have diagnosis
of rhinitis
1747 110 (6%) 1102 (60%) 626 (34%) <0.0001
Ever took medication for asthma 3605 269 (7%) 2255 (63%) 1081 (30%)
Never took medication for asthma 25 7 (28%) 16 (64%) 2 (8%) <0.0001a
No family member outside Household
W/asthma
1944 135 (7%) 1200 (62%) 609 (31%)
Family member outside household
W/Asthma
1345 110 (8%) 853 (62%) 412 (30%) 0.42
No smoker in household 2134 167 (8%) 1367 (64%) 600 (28%)
Smoker in household 1491 109 (7%) 901 (60%) 481 (32%) 0.03
No pets in household 2794 203 (7%) 1765 (63%) 826 (30%)
Pets in household 826 73 (9%) 502 (61%) 251 (30%) 0.25
Highest level of education
Primary school or less 452 29 (6%) 268 (59%) 155 (34%)
Secondary school 2115 161 (8%) 1319 (62%) 635 (30%)
University or more 1036 86 (8%) 666 (64%) 284 (27%) 0.10
a Fischer’s exact test used.
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Insights and Reality in Asia-Pacific (AIRIAP) survey, con-
ducted in 2000 [4]. This survey, which included several of
the same countries as our study, also found that level of
asthma control as measured by 2003 GINA guideline criteria
was generally poor, with over half the participants report-
ing daytime symptoms and only 14% reported usingTable 3 Associations of ever/never past 12 months-use of asthm
with work/school with level of control of asthma symptoms.
Well-controlled
n Z 276 (7.6%)
Oral steroid 70 (3.9%)
Use of quick relief/rescue medicine 155 (5.3%)
Long-term maintenance medicine 139 (5.1%)
Unscheduled/emergency health care visits 29 (2.8%)
Hospitalization 6 (1.7%)
Visits to health care provider for asthma 73 (3.6%)
Missed work/school 48 (3.1%)preventative asthma medications. A 2006 update to the
AIRIAP study, the Asthma Insights and Reality in Asia-Pacific
Phase 2 study, also used 2003 GINA guidelines, as well as the
Asthma Control Test (ACT) to define level of asthma control
[13]. Similar to our study, these authors found that asthma
patients with partly- and uncontrolled asthma were statis-
tically significantly more likely to use urgent health servicesa medications/healthcare services and absence/interference
Partly controlled Uncontrolled Chi-square p-Value
n Z 2271 (63%) n Z 1083 (30%)
1042 (59%) 669 (38%) <0.0001
1797 (62%) 970 (33%) <0.0001
1678 (62%) 897 (33%) <0.0001
536 (51%) 483 (46%) <0.0001
153 (43%) 193 (55%) <0.0001
1173 (58%) 792 (39%) <0.0001
891 (58%) 595 (39%) <0.0001
Table 4 Odds associations of mood indicators with level of control of asthma symptoms.
Well-controlled Partly controlled Uncontrolled Chi-Square p-Value
n Z 276 (7.6%) n Z 2271 (63%) n Z 1083 (30%)
Often/sometimes tired or fatigued 72 (3.2%) 1283 (58%) 866 (39%) <0.0001
Often/sometimes fearful 40 (3.6%) 595 (53%) 480 (43%) <0.0001
Often/sometimes depressed 15 (1.6%) 531 (55%) 421 (44%) <0.0001
Often/sometimes embarrassed 17 (2.1%) 415 (51%) 389 (47%) <0.0001
Often/sometimes frustrated 30 (2.4%) 709 (56%) 532 (42%) <0.0001
Strongly/somewhat agree feel lack of
control due to asthma
30 (2.3%) 686 (53%) 577 (45%) <0.0001
Strongly/somewhat agree feel
inadequate in relation to peers due
to asthma
18 (2.0%) 519 (57%) 372 (41%) <0.0001
Strongly/somewhat agree asthma
affects self-image
28 (2.3%) 684 (57%) 489 (41%) <0.0001
Table 5 Asthma interference with productivity and missed work/school by level of control of asthma symptoms.
Well-controlled
(Mean  Std. dev.)
Partly controlled
(Mean  Std. dev.)
Uncontrolled
(mean  Std. dev.)
F-test p-Value
Productivity: typical daya 91  15 82  16 77  16 <0.0001
Productivity: asthma at its worsta 59  30 50  24 44  21 <0.0001
Number of days of missed work/school 0.75  2.4 3.7  15 7.9  29 <0.0001
Abbreviation: Std. dev, standard deviation.
a Productivity measured on scale of 0e100% (higher Z more productive).
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population [12] and also found that GINA-defined level of
asthma control was associated with increased utilizations
of healthcare resources and decreased productivity. Addi-
tionally, several previous studies have used the ACT
[13e16] or the National Asthma Education Prevention Pro-
gram (NAEPP) guidelines [17] to classify level of asthma
control in order to examine the relationship between
asthma severity and outcomes. Similar to our findings,
these papers found that patients with partly- and uncon-
trolled asthma were at significantly greater risk of using
healthcare services and adverse health outcomes.
Although our study included a large population of asthma
patients that was randomly selected, it also had several
limitations. First, the nine countries included in this study
are diverse, especially in terms of healthcare delivery sys-
tems and socioeconomic indicators. Because we did not have
enough patients to conduct these analyses separately for
each country, it is possible that our results are not gener-
alizable to the general worldwide asthma population. Addi-
tionally, we did not have data on non-respondents so the
participants who agreed to take part in the survey may not
have been representative of asthma patients in general.
While the wording of the survey questions that we used to
divide our population into those with well-controlled, partly-
controlled, and uncontrolled asthma was similar to that used
in the GINA guidelines (Table 1), it did not correlate
perfectly. Also, our analyses were based on self-reported
information which may have been biased. Finally, while
this paper reports associations between poorly controlled
asthma and health outcomes, the data were cross-sectional
and we were unable to examine issues of cause and effect.This study suggests over 90% of the population of asthma
patients in nine Asia-Pacific countries had asthma that was
classified as partly- or uncontrolled by international
guideline definitions. Additionally, analyses indicated that
patients who did not have well-controlled asthma had
greater utilization rates of asthma medications and emer-
gency healthcare services and were more likely to report
absences from work and school and decreased productivity
because of their asthma compared to patients whose
asthma was well-controlled. These associations suggest
that a health policy emphasis on improving asthma control
could benefit not only patients but also the economies of
these countries as a whole as reductions in the cost of
asthma care, increases in productivity, and patient well-
being could be achieved.
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276 L.S. Gold et al.Appendix. Survey questions presented in
Tables 3e5.Abbreviated question Table Survey question Survey answers
presented in table
Oral steroid 3 (Have you/has your child) had to take an oral steroid
(pill or liquid) to manage (your/your child’s) asthma
symptoms in the past twelve months?
Yes
Use of quick relief/rescue medicine 3 When was the most recent time that (you/your child)
used medicine for quick relief or rescue from asthma
symptoms?
Within the past year
Long-term maintenance medicine 3 When was the most recent time that (you/your child)
took a medicine for the control or prevention of
(your/your child’s) asthma?
Within the past year
Unscheduled/emergency health
care visits
3 Has (your/your child’s) asthma caused any unscheduled
urgent or emergency visits to a doctors office, hospital,
clinic or somewhere else in the past 12 months?
Yes
Hospitalization 3 (Have you/Has your child) been hospitalized overnight
for asthma in the past 12 months?
Yes
Visits to health care provider for
asthma
3 In the past 12 months (have you/has your child) seen
a doctor or other health care provider because of
asthma exacerbations or worsening symptoms,
or sudden, severe asthma episodes?
Yes
Missed work/school 3 Has (your/your child’s) asthma caused (you/your child)
to miss work or school in the past year?
Yes
Often/sometimes tired or fatigued 4 As a result of (your/your child’s) asthma, how often
(do you/does he or she) feel tired or fatigued?
Often/sometimes
Often/sometimes fearful 4 As a result of (your/your child’s) asthma, how often
(do you/does he or she) feel fearful?
Often/sometimes
Often/sometimes depressed 4 As a result of (your/your child’s) asthma, how often
(do you/does he or she) feel depressed?
Often/sometimes
Often/sometimes embarrassed 4 As a result of (your/your child’s) asthma, how often
(do you/does he or she) feel embarrassed?
Often/sometimes
Often/sometimes frustrated 4 As a result of (your/your child’s) asthma, how often
(do you/does he or she) feel frustrated?
Often/sometimes
Strongly/somewhat agree feel
lack of control due to asthma
4 Do you strongly agree, somewhat agree, neither agree
nor disagree, somewhat disagree or strongly disagree
that (my/my child’s) asthma makes (me/my child)
feel like (I/they) don’t have control of (my/their) life.
Strongly agree/
somewhat agree
Strongly/somewhat agree feel
inadequate in relation to peers
due to asthma
4 Do you strongly agree, somewhat agree, neither agree
nor disagree, somewhat disagree or strongly disagree
that (I/my child) feel(s) inadequate in relation to
(my/their) peers due to (my/their) asthma.
Strongly agree/
somewhat agree
Strongly/somewhat agree asthma
affects self-image
4 Do you strongly agree, somewhat agree, neither agree
nor disagree, somewhat disagree or strongly disagree
that (my/my child’s) asthma affects how (I/my child)
feel(s) about (myself/himself/herself).
Strongly agree/
somewhat agree
Productivity: typical day 5 Thinking about productivity on a scale of 0e100,
where 100 means 100% productivity, where would you
rank (your/your child’s) productivity on a typical day?
__________%
(Range 0e100)
Productivity: asthma at its worst 5 Where would you rank (your/your child’s) productivity
on the same scale of 0e100, at times of the year
when (your/your child’s) asthma was at its worst?
__________%
(Range 0e100)
Number of days of missed
work/school
5 How many work or school days (have you/has your
child) lost in the past year as a result of asthma?
____ DAYS LOST
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